• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].

作者信息

Ar'ev A L, Chesnokov A A

出版信息

Adv Gerontol. 2013;26(3):511-7.

PMID:24640703
Abstract

The state-of-the-art review of literature on the problem of percutaneous transluminal coronary angioplasty in patients of senior age groups with sharp cardiovascular pathology is submitted in three parts. In the second part the review of epidemiology and risk factors of the contrast-induced nephropathy emergence in intervention gerontocardiology is submitted.

摘要

相似文献

1
[Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].
Adv Gerontol. 2013;26(3):511-7.
2
[Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].
Adv Gerontol. 2013;26(4):679-84.
3
[Percutaneous transluminal coronary angioplasty, X-ray contrast researches and contrast-induced nephropathy in geriatrics. Part I. Percutaneous transluminal coronary angioplasty in patients of advanced and senile age with acute cardiovascular pathology].
Adv Gerontol. 2013;26(2):315-319.
4
Risk score for contrast induced nephropathy following percutaneous coronary intervention.经皮冠状动脉介入治疗后对比剂肾病的风险评分
Saudi J Kidney Dis Transpl. 2009 Mar;20(2):240-5.
5
Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.经皮冠状动脉介入治疗中所采用的定义对造影剂肾病发生率的影响。
Am J Cardiol. 2009 Jun 15;103(12):1657-62. doi: 10.1016/j.amjcard.2009.02.039. Epub 2009 Apr 16.
6
Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.慢性肾脏病患者冠状动脉造影术后对比剂肾病的肾脏转归
Int J Cardiol. 2011 Jan 21;146(2):295-6. doi: 10.1016/j.ijcard.2010.10.090. Epub 2010 Nov 23.
7
Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.接受初次冠状动脉血管成形术患者中造影剂肾病的预测因素。
Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):424-32. doi: 10.1016/j.acvd.2014.05.008. Epub 2014 Jul 28.
8
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).在接受直接经皮冠状动脉介入治疗（PCI）的急性 ST 段抬高型心肌梗死（STEMI）患者中，等渗与低渗对比剂对造影剂肾病及组织再灌注的影响（来自对比剂与急性心肌梗死直接 PCI 后肾毒性 [CONTRAST-AMI] 试验）。
Am J Cardiol. 2012 Jan 1;109(1):67-74. doi: 10.1016/j.amjcard.2011.08.006. Epub 2011 Sep 22.
9
Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.患有既往肾功能损害的患者在接受冠状动脉造影和经皮冠状动脉腔内血管成形术时发生的造影剂肾病。
Mymensingh Med J. 2011 Apr;20(2):270-4.
10
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.一项关于碘克沙醇与碘普罗胺在接受冠状动脉造影（无论是否进行经皮冠状动脉介入治疗）的慢性肾脏病患者中的疗效及心肾安全性的前瞻性、双盲、随机对照试验。
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):958-65. doi: 10.1002/ccd.21713.